TY - JOUR
T1 - In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters
AU - Hiraiwa, Toshihisa
AU - Moriyama, Kazuhiro
AU - Matsumoto, Kana
AU - Shimomura, Yasuyo
AU - Kato, Yu
AU - Yamashita, Chizuru
AU - Hara, Yoshitaka
AU - Kawaji, Takahiro
AU - Kurimoto, Yasuyoshi
AU - Nakamura, Tomoyuki
AU - Kuriyama, Naohide
AU - Shibata, Junpei
AU - Komura, Hidefumi
AU - Morita, Kunihiko
AU - Nishida, Osamu
N1 - Publisher Copyright:
© 2020 The Author(s). Published by S. Karger AG, Basel.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Introduction: Renal replacement therapy (RRT) is widely used in the treatment of septic acute kidney injury. However, little is known about how the adsorption properties of hemofilters used in RRT affect antibiotic concentration. Because a cytokine-adsorption membrane is frequently used in RRT, it is important to determine the antibiotic adsorption capacity of this membrane. Objective: The present study aimed to investigate the antibiotic adsorption capacity of different hemofilter membranes by in vitro experiments using 2 antibacterial agents (linezolid and doripenem). Methods: We performed experimental hemofiltration in vitro using polyacrylonitrile (AN69ST), polymethylmethacrylate (PMMA), and polysulfone (PS) hemofilters for 1,440 min. The test solution was a 1,000-mL substitution fluid containing 30 μg/mL linezolid and 120 μg/mL doripenem. We measured drug concentrations at the inlet, outlet, and filtrate ports of the hemofilters for 1,440 min and calculated the sieving coefficient (SC) and adsorption rate (Ra) of the drugs onto the hemofilters. Results: The amount of linezolid adsorbed onto AN69ST, PMMA, and PS membranes was decreased relative to that in the control group at 15 min (p < 0.05). However, no SC for linezolid was obtained thereafter. The Ra of linezolid onto AN69ST, PMMA, and PS membranes was higher than that in the control group (p < 0.05). In contrast, no significant differences were observed in the concentrations and Ra values of doripenem adsorbed onto AN69ST, PMMA, and PS membranes compared with those in the control group. Conclusions: Doripenem was not adsorbed onto PMMA, PS, and AN69ST membranes. Linezolid was adsorbed onto PMMA, PS, and AN69ST membranes, but only temporarily, and this did not affect drug bioavailability.
AB - Introduction: Renal replacement therapy (RRT) is widely used in the treatment of septic acute kidney injury. However, little is known about how the adsorption properties of hemofilters used in RRT affect antibiotic concentration. Because a cytokine-adsorption membrane is frequently used in RRT, it is important to determine the antibiotic adsorption capacity of this membrane. Objective: The present study aimed to investigate the antibiotic adsorption capacity of different hemofilter membranes by in vitro experiments using 2 antibacterial agents (linezolid and doripenem). Methods: We performed experimental hemofiltration in vitro using polyacrylonitrile (AN69ST), polymethylmethacrylate (PMMA), and polysulfone (PS) hemofilters for 1,440 min. The test solution was a 1,000-mL substitution fluid containing 30 μg/mL linezolid and 120 μg/mL doripenem. We measured drug concentrations at the inlet, outlet, and filtrate ports of the hemofilters for 1,440 min and calculated the sieving coefficient (SC) and adsorption rate (Ra) of the drugs onto the hemofilters. Results: The amount of linezolid adsorbed onto AN69ST, PMMA, and PS membranes was decreased relative to that in the control group at 15 min (p < 0.05). However, no SC for linezolid was obtained thereafter. The Ra of linezolid onto AN69ST, PMMA, and PS membranes was higher than that in the control group (p < 0.05). In contrast, no significant differences were observed in the concentrations and Ra values of doripenem adsorbed onto AN69ST, PMMA, and PS membranes compared with those in the control group. Conclusions: Doripenem was not adsorbed onto PMMA, PS, and AN69ST membranes. Linezolid was adsorbed onto PMMA, PS, and AN69ST membranes, but only temporarily, and this did not affect drug bioavailability.
KW - Adsorption
KW - Doripenem
KW - Experimental model
KW - Hemofilter
KW - Linezolid
UR - http://www.scopus.com/inward/record.url?scp=85079000858&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079000858&partnerID=8YFLogxK
U2 - 10.1159/000504039
DO - 10.1159/000504039
M3 - Article
C2 - 31995801
AN - SCOPUS:85079000858
SN - 0253-5068
VL - 49
SP - 295
EP - 301
JO - Blood Purification
JF - Blood Purification
IS - 3
ER -